Incyte Corp (INCY) stock
INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$119.09−1.18 (-0.98%)
Close on Nov 17, 2026Market cap $24.27BP/E 63.3Yield –
Incyte ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Incyte's ebitda for the twelve months ending Sep 30, 2026 was $724.95M, down 53.9% year over year. For fiscal 2025 it was $1.61B, up 967.7% from the year before. Over ten years it grew 32.6% a year on average. The highest annual figure on record is $1.61B in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.61B | +967.7% |
| FY2024 | Dec 31, 2024 | $150.61M | -78.6% |
| FY2023 | Dec 31, 2023 | $703.19M | +8.6% |
| FY2022 | Dec 31, 2022 | $647.30M | +0.6% |
| FY2021 | Dec 31, 2021 | $643.62M | – |
| FY2020 | Dec 31, 2020 | -$211.87M | -146.4% |
| FY2019 | Dec 31, 2019 | $456.54M | +147.9% |
| FY2018 | Dec 31, 2018 | $184.19M | – |
| FY2017 | Dec 31, 2017 | -$191.21M | -194.0% |
| FY2016 | Dec 31, 2016 | $203.42M | +112.9% |
| FY2015 | Dec 31, 2015 | $95.53M | +161.0% |
| FY2014 | Dec 31, 2014 | $36.61M | +179.4% |
| FY2013 | Dec 31, 2013 | $13.11M | -57.9% |
| FY2012 | Dec 31, 2012 | $31.13M | – |
| FY2011 | Dec 31, 2011 | -$116.19M | -401.5% |
| FY2010 | Dec 31, 2010 | $38.53M | – |
| FY2009 | Dec 31, 2009 | -$123.08M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$684.19M | -246.3% |
| Q2 FY2026 | Jun 30, 2026 | $724.37M | +30.9% |
| Q1 FY2026 | Mar 31, 2026 | $324.92M | +42.8% |
| Q4 FY2025 | Dec 31, 2025 | $359.84M | +11.0% |
| Q3 FY2025 | Sep 30, 2025 | $467.54M | +177.3% |
| Q2 FY2025 | Jun 30, 2025 | $553.23M | – |
| Q1 FY2025 | Mar 31, 2025 | $227.53M | +99.9% |
| Q4 FY2024 | Dec 31, 2024 | $324.25M | +55.1% |
| Q3 FY2024 | Sep 30, 2024 | $168.61M | -28.6% |
| Q2 FY2024 | Jun 30, 2024 | -$456.08M | -313.0% |
| Q1 FY2024 | Mar 31, 2024 | $113.85M | +158.9% |
| Q4 FY2023 | Dec 31, 2023 | $209.03M | +136.7% |
| Q3 FY2023 | Sep 30, 2023 | $236.10M | +52.3% |
| Q2 FY2023 | Jun 30, 2023 | $214.08M | -21.0% |
| Q1 FY2023 | Mar 31, 2023 | $43.98M | -66.9% |
| Q4 FY2022 | Dec 31, 2022 | $88.31M | -29.7% |
| Q3 FY2022 | Sep 30, 2022 | $155.07M | -38.0% |
| Q2 FY2022 | Jun 30, 2022 | $270.94M | +74.5% |
| Q1 FY2022 | Mar 31, 2022 | $132.98M | +18.1% |
| Q4 FY2021 | Dec 31, 2021 | $125.59M | -29.2% |
| Q3 FY2021 | Sep 30, 2021 | $250.10M | +1268.5% |
| Q2 FY2021 | Jun 30, 2021 | $155.29M | -36.2% |
| Q1 FY2021 | Mar 31, 2021 | $112.64M | – |
| Q4 FY2020 | Dec 31, 2020 | $177.40M | +63.7% |
| Q3 FY2020 | Sep 30, 2020 | $18.28M | -87.7% |
| Q2 FY2020 | Jun 30, 2020 | $243.37M | +117.2% |
| Q1 FY2020 | Mar 31, 2020 | -$650.91M | -840.0% |
| Q4 FY2019 | Dec 31, 2019 | $108.35M | +12.6% |
| Q3 FY2019 | Sep 30, 2019 | $148.18M | +229.7% |
| Q2 FY2019 | Jun 30, 2019 | $112.05M | +15.8% |
| Q1 FY2019 | Mar 31, 2019 | $87.96M | – |
| Q4 FY2018 | Dec 31, 2018 | $96.20M | – |
| Q3 FY2018 | Sep 30, 2018 | $44.94M | +66.7% |
| Q2 FY2018 | Jun 30, 2018 | $96.74M | +393.3% |
| Q1 FY2018 | Mar 31, 2018 | -$53.69M | – |
| Q4 FY2017 | Dec 31, 2017 | -$119.56M | -300.5% |
| Q3 FY2017 | Sep 30, 2017 | $26.96M | – |
| Q2 FY2017 | Jun 30, 2017 | $19.61M | – |
| Q1 FY2017 | Mar 31, 2017 | -$118.22M | – |
| Q4 FY2016 | Dec 31, 2016 | $59.65M | – |
See a number that looks wrong?